This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Novartis Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Inventor Markus Fendt
Introduction
Markus Fendt is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medical science, particularly in the area of anesthesia. His work focuses on enhancing patient safety and recovery during medical procedures.
Latest Patents
Markus Fendt holds a patent for the "Use of alpha 7 nicotinic acetylcholine receptor agonists." This invention concerns the use of specific alpha 7 nicotinic acetylcholine receptor agonists to facilitate emergence from general anesthesia. This innovative approach aims to improve the recovery process for patients undergoing surgical procedures.
Career Highlights
Fendt is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on groundbreaking research and development projects that aim to advance medical treatments and improve patient outcomes.
Collaborations
Throughout his career, Markus has collaborated with esteemed colleagues, including Dominik Feuerbach and Sjoerd Johannes Finnema. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Markus Fendt's contributions to the field of anesthesia through his patent and work at Novartis AG highlight his commitment to improving medical practices. His innovative approach continues to influence the way anesthesia is administered and managed in clinical settings.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile